Danske Invest China vs UBS Lux Equity Fund Biotech USD

Danske Invest China vs UBS Lux Equity Fund Biotech USD

1. Danske Invest China

  • Security

    Danske Invest China A

  • Fee

    2.15%

  • ISIN

    LU0178668348

  • Holdings

    6

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

Fund Holdings

We have information about 9 holdings in Danske Invest China, where the largest holding is BYD (2.56), followed by NetEase ADR (2.36) and JD.com (1.47). In comparison with UBS Lux Equity Fund Biotech USD, we have 14 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Vertex (9.9) and Moderna (9.21).

All Holdings

Here we compare the holdings in Danske Invest China and UBS Lux Equity Fund Biotech USD.

Danske Invest China UBS Lux Equity Fund Biotech USD
1. BYD Co Ltd Class H
China
2.56 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. NetEase ADR
China
2.36 %
2. Vertex Pharmaceuticals Inc
9.9 %
3. JD.com Inc
China
1.47 %
3. Moderna Inc
9.21 %
4. Xpeng Inc
1.27 %
4. Alnylam Pharmaceuticals Inc
6.54 %
5. Industrial and Commercial Bank of China Ltd Class H
China
1.25 %
5. AbbVie Inc
USA
5.52 %
6. Wuxi AppTec Co Ltd
China
1.01 %
6. Gilead Sciences Inc
USA
4.66 %
- 7. Amgen Inc
4.32 %
- 8. BioNTech SE
4.13 %
- 9. Karuna Therapeutics Inc
3.75 %
- 10. Royalty Pharma Plc
3.28 %

The list of fund holdings was last updated on April 18, 2025.